Clovis Oncology Profile

63.77
USD 0.36  0.56%
57.69Last Month High 64.14 
62.5Trading Day  High 64.41 

Exercise or conversion by Hooks Corwin Dale of 868 shares of Clovis Oncology subject to Rule 16b-3

Clovis Oncology Inc insider trading alert for exercise of restricted stock units by Hooks Corwin Dale, Senior Vice President and Chief Commercial Officer, on December 1, 2017. This event was filed by Clovis Oncology Inc with SEC on 2017-12-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Clovis Oncology Summary

Clovis Oncology Inc (CLVS) is traded on NASDAQ in USA. It is located in COLORADO, U.S.A and employs 309 people. Clovis Oncology is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 3.13 B. Clovis Oncology Inc has 49.01 M outstanding shares of which 6.95 M shares are currently shorted by private and institutional investors with about 5.48 trading days to cover. Clovis Oncology currently holds about 627.97 M in cash with (250 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.81.
Check Clovis Oncology Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares3.9 M319 M
Blackrock IncCommon Shares3.6 M296.4 M
Linden Advisors LpDebt69.3 M107.3 M
View Clovis Oncology Diagnostics

Selected Clovis Oncology Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Clovis Oncology Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 13% 
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anticancer agents in the United States, Europe, and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameClovis Oncology Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCOLORADO, U.S.A
Business Address5500 Flatiron Parkway, Suite 100, Boulder, CO 80301, United States
ExchangeNASDAQ
CIK Number01466301.0
CUSIP189464100
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.clovisoncology.com
Contact Number303 625 5000
CurrencyUSD - US Dollar

Recommendations

Clovis Oncology Analyst Recommendations
Target PriceAdvice# of Analysts
65.29Hold7Odds
Clovis Oncology Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Clovis Oncology Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Clovis Oncology Earnings Estimates
EPSEstimate Date
Quarterly Estimate-1.43May 4, 2017
Clovis Oncology Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate